Manganese-enhanced MRI in a rat model of Parkinson's disease

Galit Pelled1, Hagai Bergman, Tamir Ben-Hur

  • 1MRI/MRS Laboratory, Human Biology Research Center, Department of Medical Biophysics and Nuclear Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel.

Abstract

Insights

Parkinson's disease (PD) in rats shows altered brain connectivity. Manganese-enhanced MRI reveals changes in basal ganglia (BG) networks, supporting the interhemispheric connectivity hypothesis in PD.

Area of Science:

  • Neuroscience
  • Neuroimaging
  • Parkinson's Disease Research

Background:

  • The basal ganglia (BG) play a crucial role in motor control.
  • Altered connectivity within and between BG nuclei is implicated in Parkinson's disease (PD).
  • The interhemispheric connectivity hypothesis proposes significant changes in BG network communication in PD.

Purpose of the Study:

  • To investigate intra- and inter-hemispheric BG connectivity in a unilateral 6-hydroxydopamine (6-OHDA) rat model of PD.
  • To test the validity of the BG interhemispheric connectivity hypothesis in this PD model.

Main Methods:

  • Utilized manganese-enhanced MRI (MEMRI) for assessing neural pathway activity.
  • Administered manganese chloride via direct injection into key BG nuclei: entopeduncular (EP), substantia nigra (SN), and habenula.
  • Compared MEMRI signal enhancements in 6-OHDA lesioned rats (N=22) versus sham-operated controls (N=16) at multiple time points post-injection.

Main Results:

  • EP nucleus manganese injection showed bilateral habenular enhancement, more pronounced in 6-OHDA rats, and reduced sensorimotor cortex signal.
  • SN manganese injection led to increased thalamic and habenular signals in 6-OHDA rats.
  • Habenula manganese injection revealed heightened interpeduncular and raphe nuclei signals in 6-OHDA rats.

Conclusions:

  • Observed modulations in intra- and interhemispheric BG connectivity in the 6-OHDA PD rat model support the interhemispheric connectivity hypothesis.
  • Findings suggest a potential link between dopaminergic and serotonergic systems in PD pathophysiology, correlating with clinical symptoms.